Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Buy
25,476
+11,861
+87% +$1.37M 0.79% 36
2025
Q4
$1.43M Sell
13,615
-1,806
-12% -$170K 0.36% 61
2025
Q3
$1.29M Sell
15,421
-9,815
-39% -$808K 0.3% 71
2025
Q2
$2M Buy
25,236
+308
+1% +$24.5K 0.5% 51
2025
Q1
$2.24M Buy
24,928
+697
+3% +$65.1K 0.62% 47
2024
Q4
$2.41M Sell
24,231
-6,120
-20% -$631K 0.69% 41
2024
Q3
$3.45M Buy
30,351
+1,399
+5% +$166K 0.99% 29
2024
Q2
$3.58M Sell
28,952
-56
-0.2% -$7.21K 1.12% 24
2024
Q1
$3.83M Buy
29,008
+1,065
+4% +$131K 1.27% 23
2023
Q4
$3.05M Buy
27,943
+28
+0.1% +$2.91K 1.11% 27
2023
Q3
$2.87M Buy
27,915
+4,000
+17% +$431K 1.18% 23
2023
Q2
$2.76M Buy
23,915
+907
+4% +$103K 1.17% 24
2023
Q1
$2.45M Sell
23,008
-6,300
-21% -$680K 1.15% 26
2022
Q4
$3.25M Buy
29,308
+783
+3% +$80K 1.61% 18
2022
Q3
$2.46M Buy
28,525
+2,575
+10% +$230K 1.31% 22
2022
Q2
$2.37M Buy
25,950
+4,571
+21% +$405K 1.27% 25
2022
Q1
$1.75M Buy
21,379
+5,756
+37% +$454K 0.9% 36
2021
Q4
$1.2M Sell
15,623
-28
-0.2% -$2.23K 0.63% 52
2021
Q3
$1.18M Sell
15,651
-321
-2% -$24.4K 0.69% 43
2021
Q2
$1.24M Sell
15,972
-27,879
-64% -$2.07M 0.67% 50
2021
Q1
$3.23M Buy
43,851
+38,621
+738% +$2.85M 1.14% 32
2020
Q4
$408K Buy
5,230
+412
+9% +$31.5K 0.3% 73
2020
Q3
$381K Hold
4,818
0.32% 73
2020
Q2
$355K Sell
4,818
-815
-14% -$61.4K 0.33% 74
2020
Q1
$414K Sell
5,633
-103
-2% -$8.1K 0.45% 56
2019
Q4
$501K Buy
5,736
+937
+20% +$77K 0.43% 67
2019
Q3
$388K Buy
4,799
+75
+2% +$6.01K 0.29% 85
2019
Q2
$370 Buy
4,724
+37
+0.8% +$2.83K 0.25% 86
2019
Q1
$374K Sell
4,687
-48
-1% -$3.59K 0.28% 82
2018
Q4
$348K Buy
+4,735
New +$334K 0.34% 81

Other funds holding MRK

Little House Capital's MRK Position: Q1 2026 in Review

Little House Capital increased its Merck (MRK) stake by 87% in Q1 2026, buying an estimated $1.37M and bringing the position to 25,476 shares worth $3.06M. The position accounts for 0.79% of the portfolio, ranked #36.

Little House Capital first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.83M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Little House Capital held 25,476 shares of Merck worth $3.06M as of Q1 2026.
  • Little House Capital bought 11,861 Merck shares in Q1 2026, an estimated $1.37M.
  • Merck made up 0.79% of Little House Capital's portfolio in Q1 2026, its #36 holding.
  • Little House Capital first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Little House Capital's Merck position peaked at $3.83M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Little House Capital's 13F filing for Q1 2026, filed 7 May 2026.